liraglutide

Generic: liraglutide

Labeler: cipla usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name liraglutide
Generic Name liraglutide
Labeler cipla usa inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

liraglutide 6 mg/mL

Manufacturer
Cipla USA Inc.

Identifiers & Regulatory

Product NDC 69097-920
Product ID 69097-920_30ecdada-240d-4f5b-a900-5705e4b500be
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217590
Listing Expiration 2027-12-31
Marketing Start 2026-01-22

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097920
Hyphenated Format 69097-920

Supplemental Identifiers

RxCUI
897122
UNII
839I73S42A
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name liraglutide (source: ndc)
Generic Name liraglutide (source: ndc)
Application Number ANDA217590 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 2 SYRINGE, PLASTIC in 1 CARTON (69097-920-67) / 3 mL in 1 SYRINGE, PLASTIC
  • 3 SYRINGE, PLASTIC in 1 CARTON (69097-920-68) / 3 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (2)

Ingredients (1)

liraglutide (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "30ecdada-240d-4f5b-a900-5705e4b500be", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "rxcui": ["897122"], "spl_set_id": ["8fe557ae-4ff0-47a2-8ec3-37bb0fbdcc64"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, PLASTIC in 1 CARTON (69097-920-67)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "69097-920-67", "marketing_start_date": "20260122"}, {"sample": false, "description": "3 SYRINGE, PLASTIC in 1 CARTON (69097-920-68)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "69097-920-68", "marketing_start_date": "20260122"}], "brand_name": "LIRAGLUTIDE", "product_id": "69097-920_30ecdada-240d-4f5b-a900-5705e4b500be", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "69097-920", "generic_name": "LIRAGLUTIDE", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIRAGLUTIDE", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "6 mg/mL"}], "application_number": "ANDA217590", "marketing_category": "ANDA", "marketing_start_date": "20260122", "listing_expiration_date": "20271231"}